Fresh sell signal · US Health Care
Kyverna Therapeutics: sell signal in week 1, trading not recommended
Fresh sell signal · US Health Care
In Summary
Kyverna Therapeutics enters week 1 of a sell signal, ranking 9th among the 96 sell signals for US stocks. The week was indecisive — minimal decline — but the weekly structure remains bearish and indicators point to distribution pressure. The quality band flags trading as not recommended: the confirmation week is still in progress.
Fresh sell signal
·1st week from start
·US stocks
·T2
IQS Phase
81
in tension / maturity
Signal Strength
10
indecisive week
Sizing
MINIMUM
Ranking
#9 / 96
New us stocks
Trade P&L %
+0.00%
from signal to today
restricted Platinum content